文献速递免疫规划

佐剂依赖性地影响致病性奈瑟菌鼻腔和生殖道定植临床前模型中疫苗诱导的体液应答和保护作用

Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria.
PubMed 文献 · Vaccine · 2025-01-15

研究利用雌性小鼠下生殖道淋病奈瑟菌定植模型和上呼吸道脑膜炎奈瑟菌定植模型,评估不同免疫学特性佐剂配制的转铁蛋白结合蛋白B(TbpB)疫苗的保护效果。结果显示保护作用受佐剂选择影响:Th1/2平衡佐剂对淋病奈瑟菌保护最佳,Th1/2平衡和Th2偏向佐剂均显著降低脑膜炎奈瑟菌负荷;保护状态与体液应答或杀菌滴度无相关性。

要点

  • Th1/2平衡佐剂对淋病奈瑟菌保护最佳,Th2偏向佐剂对脑膜炎奈瑟菌也显著降低负荷
  • 保护状态与体液应答或杀菌滴度无相关性
  • 研究支持单一疫苗配方实现泛奈瑟菌覆盖的可行性

核心结论

  • 疫苗介导的保护受佐剂选择影响,Th1/2平衡佐剂对淋病奈瑟菌保护最佳,Th1/2平衡和Th2偏向佐剂均显著降低脑膜炎奈瑟菌负荷。
  • 保护状态与体液应答或杀菌滴度无相关性。
  • 研究支持单一疫苗配方实现泛奈瑟菌覆盖的可行性。

研究设计与样本

  • 研究使用雌性小鼠下生殖道淋病奈瑟菌定植模型和上呼吸道脑膜炎奈瑟菌定植模型。
  • 评估转铁蛋白结合蛋白B(TbpB)疫苗配制以免疫学不同的疫苗佐剂后的表现。

主要发现

  • 疫苗介导的保护受佐剂选择影响,Th1/2平衡佐剂对淋病奈瑟菌保护最佳。
  • Th1/2平衡和Th2偏向佐剂均导致脑膜炎奈瑟菌负荷显著降低。
  • 保护状态与体液应答或杀菌滴度之间缺乏相关性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neisseria gonorrhoeae, which causes the sexually transmitted infection gonorrhea and Neisseria meningitidis, a leading cause of bacterial meningitis and septicemia, are closely related human-restricted pathogens that inhabit distinct primary mucosal niches. While successful vaccines against invasive meningococcal disease have been available for decades, the rapid rise in antibiotic resistance has led to an urgent need to develop an effective gonococcal vaccine. Several surface antigens are shared among these two pathogens, making cross-species protection an exciting prospect. However, the type of vaccine-mediated immune response required to achieve protection against respiratory versus genital infection remains ill defined. In this study, we utilize well established mouse models of female lower genital tract colonization by N. gonorrhoeae and upper respiratory tract colonization by N. meningitidis to examine the performance of transferrin binding protein B (TbpB) vaccines formulated with immunologically distinct vaccine adjuvants. We demonstrate that vaccine-mediated protection is influenced by the choice of adjuvant, with Th1/2-balanced adjuvants performing optimally against N. gonorrhoeae, and both Th1/2-balanced and Th2-skewing adjuvants leading to a significant reduction in N. meningitidis burden. We further establish a lack of correlation between protection status and the humoral response or bactericidal titre. Combined, this work supports the feasibility for a single vaccine formulation to achieve pan-neisserial coverage.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Islam EA, Fegan JE, Zeppa JJ, et al. Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria. Vaccine. 2025. PMID: 39817984. doi:10.1016/j.vaccine.2025.126709

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。